Cereius

Cereius specializes in developing next-generation targeted radiotherapeutics (TRTs) designed to deliver radiation precisely to cancer cells, thereby increasing treatment efficacy and minimizing damage to healthy tissues. The company's proprietary modular platform enhances the delivery of radiation to tumors, improving both safety and effectiveness. Cereius operates in the oncology market, serving cancer patients and healthcare providers seeking advanced treatment options. The business model is centered around drug discovery and development, leveraging a deep understanding of cancer biology and extensive experience in the field. Revenue is generated through the development and commercialization of innovative cancer therapies.

Keywords: targeted radiotherapeutics, cancer treatment, precision medicine, oncology, modular platform, drug discovery, radiation therapy, tumor targeting, healthcare innovation, cancer biology.